Immunomedics, Inc. · Morris Plains, NJ United States (NASDAQ: IMMU)
| 300 American Rd. | Phone: 973-605-8200 |
| Morris Plains, NJ | Fax: 973-605-8282 |
| 07950 | |
| United States | 
Map This Company |
Immunomedics, Inc. Rankings
More Companies in These Related Industries: Cosmetics & Toiletries Wholesalers, Pharmaceutical Preparation MfgCompany Description
Immunomedics is focused on developing humanized monoclonal antibodies (MAbs) to treat cancer and other serious diseases. Its lead product, epratuzumab, is in development for the treatment of lupus; biopharmaceutical firm
Immunomedics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: IMMU Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Employees | 121 |
Executives
31 executives listed for Immunomedics, Inc.'s Morris Plains, NJ location.
| Chairman, Chief Strategic Officer, Chief Scientific Officer, and Chief Medical Officer | David Goldenberg | |
|---|---|---|
| President, CEO, and Director | Cynthia Sullivan | |
| SVP Finance and Business Development, and CFO | Gerard Gorman |